LifeGoal Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
DLA
MSV
FFA
KFP
RT
AAA
TFA
CP
VCM
LifeGoal Wealth Advisors's BMY Position: Q3 2026 in Review
LifeGoal Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 5.6% in Q3 2026, selling an estimated $19.8K and leaving 5,305 shares worth $331K. The position accounts for 0.1% of the portfolio, ranked #125.
LifeGoal Wealth Advisors first reported a position in BMY in Q1 2026 and has held it in 3 quarters since. The position peaked at $421K in Q1 2026. 129 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- LifeGoal Wealth Advisors held 5,305 shares of Bristol-Myers Squibb worth $331K as of Q3 2026.
- LifeGoal Wealth Advisors sold 313 Bristol-Myers Squibb shares in Q3 2026, an estimated $19.8K.
- Bristol-Myers Squibb made up 0.1% of LifeGoal Wealth Advisors's portfolio in Q3 2026, its #125 holding.
- LifeGoal Wealth Advisors first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 3 quarters since.
- LifeGoal Wealth Advisors's Bristol-Myers Squibb position peaked at $421K in Q1 2026.
- 129 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on LifeGoal Wealth Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.